Oleandrin and the its derivative odorsoside A, both cardiac enoglycosides, exhibit anti-cancer effects by inhibiting invasion via suppressing the STAT-3 signaling pathwayopen access

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.